← Browse by Condition
Medical Condition

resectable stage ii iiia squamous nsclc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07398937 Phase 2
Recruiting

Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC

Enrollment
116 pts
Location
China
Sponsor
Fudan University
View Trial →